Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2018

01-05-2018 | Original Article

Achalasia Patients Are at Nutritional Risk Regardless of Presenting Weight Category

Authors: Carolyn Newberry, Ravy K. Vajravelu, Octavia Pickett-Blakely, Gary Falk, Yu Xiao Yang, Kristle L. Lynch

Published in: Digestive Diseases and Sciences | Issue 5/2018

Login to get access

Abstract

Background

Achalasia is an esophageal motor disorder that leads to swallowing dysfunction and weight loss. Nutritional risk in achalasia patients is not well defined.

Aims

The aims of this study were to define baseline body mass index (BMI), changes in weight, and nutritional risk over time in a large cohort of achalasia patients.

Methods

This was a retrospective cohort study of achalasia patients at a tertiary care center with documented BMI, symptom severity as per Eckardt score, and nutritional risk assessment as per the Malnutrition Universal Screening Tool, which considers BMI, degree of recent weight loss, and acuity of disease.

Results

Among the 337 patients presenting for achalasia management, 179 had confirmed disease. Upon presentation 69.8% of patients were classified as overweight or obese. Using the Malnutrition Universal Screening Tool, we found 50% of patients to be at moderate or high risk for malnutrition at presentation. Eckardt score (OR 1.15, 95% CI 1.05–1.26), duration of disease (OR for each additional month 1.04, 95% CI 1.01–1.08), and female gender (OR 1.76, 95% CI 1.02–3.03) were independent predictors of increased risk for malnutrition. Nutrition risk score decreased after therapy in 93.3% of patients.

Conclusions

Despite a high prevalence of overweight and obese status in achalasia patients, many are at risk of developing nutritional complications secondary to rapid weight loss. This risk frequently resolves post-treatment. Regardless of baseline BMI, we recommend all patients undergo nutritional assessment to identify high-risk patients who may benefit from dietary intervention and expedited therapy.
Literature
1.
go back to reference Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of Achalasia. Am J Gastroenterol. 2013;108:1238–1249.CrossRefPubMed Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of Achalasia. Am J Gastroenterol. 2013;108:1238–1249.CrossRefPubMed
2.
go back to reference Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319.CrossRefPubMed Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319.CrossRefPubMed
3.
go back to reference Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Major complications of pneumatic dilation and Heller myotomy for Achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107:1817–1825.CrossRefPubMed Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Major complications of pneumatic dilation and Heller myotomy for Achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107:1817–1825.CrossRefPubMed
4.
go back to reference Gunasingam N, Perczuk A, Talbot M, Kaffes A, Saxena P. Update on therapeutic interventions for the management of achalasia. J Gastroenterol Hepatol. 2016;31:1422–1428.CrossRefPubMed Gunasingam N, Perczuk A, Talbot M, Kaffes A, Saxena P. Update on therapeutic interventions for the management of achalasia. J Gastroenterol Hepatol. 2016;31:1422–1428.CrossRefPubMed
5.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. J Neurogastroenterol Motil. 2015;27:160–174.CrossRef Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. J Neurogastroenterol Motil. 2015;27:160–174.CrossRef
6.
go back to reference Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24:57–65.CrossRefPubMedPubMedCentral Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24:57–65.CrossRefPubMedPubMedCentral
7.
go back to reference Ulijaszek SJ. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000:252. WHO Technical Report Series 894. Ulijaszek SJ. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000:252. WHO Technical Report Series 894.
8.
go back to reference Todorovic V, Russell C, Elia M. The ‘MUST’ Explanatory Booklet: A Guide to the ‘Malnutrition Universal Screening Tool’ (‘MUST’) for Adults. Malnutrition Action Group: A Standing Committee of BAPEN; 2003. Todorovic V, Russell C, Elia M. The ‘MUST’ Explanatory Booklet: A Guide to the ‘Malnutrition Universal Screening Tool’ (‘MUST’) for Adults. Malnutrition Action Group: A Standing Committee of BAPEN; 2003.
9.
go back to reference Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005–2014. JAMA. 2016;315:2284.CrossRefPubMed Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005–2014. JAMA. 2016;315:2284.CrossRefPubMed
10.
go back to reference Rakita SS, Villadolid D, Kalipersad C, Thometz D, Rosemurgy A. BMI affects presenting symptoms of Achalasia and outcome after Heller myotomy. Surg Endosc. 2007;21:258–264.CrossRefPubMed Rakita SS, Villadolid D, Kalipersad C, Thometz D, Rosemurgy A. BMI affects presenting symptoms of Achalasia and outcome after Heller myotomy. Surg Endosc. 2007;21:258–264.CrossRefPubMed
11.
go back to reference Ross SW, Oommen B, Wormer BA, et al. National outcomes of laparoscopic Heller myotomy: operative complications and risk factors for adverse events. Surg Endosc. 2015;29:3097–3105.CrossRefPubMed Ross SW, Oommen B, Wormer BA, et al. National outcomes of laparoscopic Heller myotomy: operative complications and risk factors for adverse events. Surg Endosc. 2015;29:3097–3105.CrossRefPubMed
12.
go back to reference Fisichella PM, Raz D, Palazzo F, Niponmick I, Patti MG. Clinical, radiological, and manometric profile in 145 patients with untreated Achalasia. World J Surg. 2008;32:1974–1979.CrossRefPubMed Fisichella PM, Raz D, Palazzo F, Niponmick I, Patti MG. Clinical, radiological, and manometric profile in 145 patients with untreated Achalasia. World J Surg. 2008;32:1974–1979.CrossRefPubMed
13.
go back to reference Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of Achalasia. Clin Gastroenterol Hepatol. 2010;8:30–35.CrossRefPubMed Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of Achalasia. Clin Gastroenterol Hepatol. 2010;8:30–35.CrossRefPubMed
14.
go back to reference Jeon HH, Kim JH, Youn YH, Park H, Conklin JL. Clinical characteristics of patients with untreated Achalasia. J Neurogastroenterol Motil. 2017;23:378–384.CrossRefPubMedPubMedCentral Jeon HH, Kim JH, Youn YH, Park H, Conklin JL. Clinical characteristics of patients with untreated Achalasia. J Neurogastroenterol Motil. 2017;23:378–384.CrossRefPubMedPubMedCentral
Metadata
Title
Achalasia Patients Are at Nutritional Risk Regardless of Presenting Weight Category
Authors
Carolyn Newberry
Ravy K. Vajravelu
Octavia Pickett-Blakely
Gary Falk
Yu Xiao Yang
Kristle L. Lynch
Publication date
01-05-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4985-8

Other articles of this Issue 5/2018

Digestive Diseases and Sciences 5/2018 Go to the issue